APO Research
Talk to an analyst

APO RESEARCH · REPORT

C-X-C Chemokine Receptor Type 2

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global C-X-C Chemokine Receptor Type 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025189 pages

Choose your research edition.

Industry ResearchC-X-C Chemokine Receptor Type 2 Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal C-X-C Chemokine Receptor Type 2 Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal C-X-C Chemokine Receptor Type 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C-X-C Chemokine Receptor Type 2 Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal C-X-C Chemokine Receptor Type 2 Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global C-X-C Chemokine Receptor Type 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for C-X-C Chemokine Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for C-X-C Chemokine Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for C-X-C Chemokine Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for C-X-C Chemokine Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of C-X-C Chemokine Receptor Type 2 include ChemoCentryx Inc, Dompe Farmaceutici SpA, Syntrix Biosystems Inc, AstraZeneca Plc, GlaxoSmithKline Plc and Novartis AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global C-X-C Chemokine Receptor Type 2 market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of C-X-C Chemokine Receptor Type 2 and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents C-X-C Chemokine Receptor Type 2 revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the C-X-C Chemokine Receptor Type 2 market size, projected growth trends, production technologies, key applications, and end-use industries.

C-X-C Chemokine Receptor Type 2 Segment by Company

ChemoCentryx Inc

Dompe Farmaceutici SpA

Syntrix Biosystems Inc

AstraZeneca Plc

GlaxoSmithKline Plc

Novartis AG

C-X-C Chemokine Receptor Type 2 Segment by Type

SX-517

PAC-G31P

DF-2755A

AZD-5069

Others

C-X-C Chemokine Receptor Type 2 Segment by Application

Prostate Cancer

Cornary Artery Disease

Liver Transplant Rejection

Pulmonary Inflammation

Others

C-X-C Chemokine Receptor Type 2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C-X-C Chemokine Receptor Type 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C-X-C Chemokine Receptor Type 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C-X-C Chemokine Receptor Type 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of C-X-C Chemokine Receptor Type 2 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global C-X-C Chemokine Receptor Type 2 industry.

Chapter 3: Detailed analysis of C-X-C Chemokine Receptor Type 2 companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, C-X-C Chemokine Receptor Type 2revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global C-X-C Chemokine Receptor Type 2 Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of SX-517 Table 3. Key Players of PAC-G31P Table 4. Key Players of DF-2755A Table 3. Key Players of AZD-5069 Table 4. Key Players of Others Table 5. Global C-X-C Chemokine Receptor Type 2 Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Prostate Cancer Table 7. Key Players of Cornary Artery Disease Table 8. Key Players of Liver Transplant Rejection Table 9. Key Players of Pulmonary Inflammation Table 10. Key Players of Others Table 11. Global C-X-C Chemokine Receptor Type 2 Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global C-X-C Chemokine Receptor Type 2 Market Size by Region (2021-2026) & (US$ Million) Table 13. Global C-X-C Chemokine Receptor Type 2 Market Share by Region (2021-2026) Table 14. Global C-X-C Chemokine Receptor Type 2 Market Size by Region (2027-2032) & (US$ Million) Table 15. Global C-X-C Chemokine Receptor Type 2 Market Share by Region (2027-2032) Table 16. C-X-C Chemokine Receptor Type 2 Industry Trends Table 17. C-X-C Chemokine Receptor Type 2 Industry Drivers Table 18. C-X-C Chemokine Receptor Type 2 Industry Opportunities and Challenges Table 19. C-X-C Chemokine Receptor Type 2 Industry Restraints Table 20. Global C-X-C Chemokine Receptor Type 2 Revenue by Company (US$ Million) & (2021-2026) Table 21. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Company (2021-2026) Table 22. Global C-X-C Chemokine Receptor Type 2 Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global C-X-C Chemokine Receptor Type 2 Key Company Head Office and Area Served Table 24. Global C-X-C Chemokine Receptor Type 2 Company, Product Type & Application Table 25. Global C-X-C Chemokine Receptor Type 2 Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global C-X-C Chemokine Receptor Type 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global C-X-C Chemokine Receptor Type 2 Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global C-X-C Chemokine Receptor Type 2 Market Size by Type (2021-2026) & (US$ Million) Table 30. Global C-X-C Chemokine Receptor Type 2 Market Size by Type (2027-2032) & (US$ Million) Table 31. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Type (2021-2026) Table 32. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Type (2027-2032) Table 33. Global C-X-C Chemokine Receptor Type 2 Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global C-X-C Chemokine Receptor Type 2 Market Size by Application (2021-2026) & (US$ Million) Table 35. Global C-X-C Chemokine Receptor Type 2 Market Size by Application (2027-2032) & (US$ Million) Table 36. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Application (2021-2026) Table 37. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Application (2027-2032) Table 38. ChemoCentryx Inc Company Information Table 39. ChemoCentryx Inc Business Overview Table 40. ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Product Portfolio Table 42. ChemoCentryx Inc Recent Development Table 43. Dompe Farmaceutici SpA Company Information Table 44. Dompe Farmaceutici SpA Business Overview Table 45. Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Product Portfolio Table 47. Dompe Farmaceutici SpA Recent Development Table 48. Syntrix Biosystems Inc Company Information Table 49. Syntrix Biosystems Inc Business Overview Table 50. Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Product Portfolio Table 52. Syntrix Biosystems Inc Recent Development Table 53. AstraZeneca Plc Company Information Table 54. AstraZeneca Plc Business Overview Table 55. AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Product Portfolio Table 57. AstraZeneca Plc Recent Development Table 58. GlaxoSmithKline Plc Company Information Table 59. GlaxoSmithKline Plc Business Overview Table 60. GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Product Portfolio Table 62. GlaxoSmithKline Plc Recent Development Table 63. Novartis AG Company Information Table 64. Novartis AG Business Overview Table 65. Novartis AG C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Novartis AG C-X-C Chemokine Receptor Type 2 Product Portfolio Table 67. Novartis AG Recent Development Table 68. North America C-X-C Chemokine Receptor Type 2 Market Size by Type (2021-2026) & (US$ Million) Table 69. North America C-X-C Chemokine Receptor Type 2 Market Size by Type (2027-2032) & (US$ Million) Table 70. North America C-X-C Chemokine Receptor Type 2 Market Size by Application (2021-2026) & (US$ Million) Table 71. North America C-X-C Chemokine Receptor Type 2 Market Size by Application (2027-2032) & (US$ Million) Table 72. North America C-X-C Chemokine Receptor Type 2 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 73. North America C-X-C Chemokine Receptor Type 2 Market Size by Country (2021-2026) Table 74. North America C-X-C Chemokine Receptor Type 2 Market Size by Country (2027-2032) Table 75. Europe C-X-C Chemokine Receptor Type 2 Market Size by Type (2021-2026) & (US$ Million) Table 76. Europe C-X-C Chemokine Receptor Type 2 Market Size by Type (2027-2032) & (US$ Million) Table 77. Europe C-X-C Chemokine Receptor Type 2 Market Size by Application (2021-2026) & (US$ Million) Table 78. Europe C-X-C Chemokine Receptor Type 2 Market Size by Application (2027-2032) & (US$ Million) Table 79. Europe C-X-C Chemokine Receptor Type 2 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. Europe C-X-C Chemokine Receptor Type 2 Market Size by Country (2021-2026) Table 81. Europe C-X-C Chemokine Receptor Type 2 Market Size by Country (2027-2032) Table 82. China C-X-C Chemokine Receptor Type 2 Market Size by Type (2021-2026) & (US$ Million) Table 83. China C-X-C Chemokine Receptor Type 2 Market Size by Type (2027-2032) & (US$ Million) Table 84. China C-X-C Chemokine Receptor Type 2 Market Size by Application (2021-2026) & (US$ Million) Table 85. China C-X-C Chemokine Receptor Type 2 Market Size by Application (2027-2032) & (US$ Million) Table 86. Asia C-X-C Chemokine Receptor Type 2 Market Size by Type (2021-2026) & (US$ Million) Table 87. Asia C-X-C Chemokine Receptor Type 2 Market Size by Type (2027-2032) & (US$ Million) Table 88. Asia C-X-C Chemokine Receptor Type 2 Market Size by Application (2021-2026) & (US$ Million) Table 89. Asia C-X-C Chemokine Receptor Type 2 Market Size by Application (2027-2032) & (US$ Million) Table 90. Asia C-X-C Chemokine Receptor Type 2 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. Asia C-X-C Chemokine Receptor Type 2 Market Size by Country (2021-2026) Table 92. Asia C-X-C Chemokine Receptor Type 2 Market Size by Country (2027-2032) Table 93. South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Type (2021-2026) & (US$ Million) Table 94. South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Type (2027-2032) & (US$ Million) Table 95. South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Application (2021-2026) & (US$ Million) Table 96. South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Application (2027-2032) & (US$ Million) Table 97. South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Country (2021-2026) Table 99. South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Country (2027-2032) Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. C-X-C Chemokine Receptor Type 2 Product Image Figure 2. Global C-X-C Chemokine Receptor Type 2 Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global C-X-C Chemokine Receptor Type 2 Market Share by Type: 2025 VS 2032 Figure 4. SX-517 Image Figure 5. PAC-G31P Image Figure 6. DF-2755A Image Figure 7. AZD-5069 Image Figure 8. Others Image Figure 9. Global C-X-C Chemokine Receptor Type 2 Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global C-X-C Chemokine Receptor Type 2 Market Share by Application: 2025 VS 2032 Figure 11. Prostate Cancer Image Figure 12. Cornary Artery Disease Image Figure 13. Liver Transplant Rejection Image Figure 14. Pulmonary Inflammation Image Figure 15. Others Image Figure 16. Global C-X-C Chemokine Receptor Type 2 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 18. Global C-X-C Chemokine Receptor Type 2 Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global C-X-C Chemokine Receptor Type 2 Market Share by Players in 2025 Figure 21. Global Top 5 and 10 C-X-C Chemokine Receptor Type 2 Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global C-X-C Chemokine Receptor Type 2 Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Type (2021-2032) Figure 25. Global C-X-C Chemokine Receptor Type 2 Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Application (2021-2032) Figure 27. North America C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 28. North America C-X-C Chemokine Receptor Type 2 Market Share by Type (2021-2032) Figure 29. North America C-X-C Chemokine Receptor Type 2 Market Share by Application (2021-2032) Figure 30. North America C-X-C Chemokine Receptor Type 2 Market Share by Country (2021-2032) Figure 31. United States C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 32. Canada C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 33. Mexico C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 34. Europe C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 35. Europe C-X-C Chemokine Receptor Type 2 Market Share by Type (2021-2032) Figure 36. Europe C-X-C Chemokine Receptor Type 2 Market Share by Application (2021-2032) Figure 37. Europe C-X-C Chemokine Receptor Type 2 Market Share by Country (2021-2032) Figure 38. Germany C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 39. France C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 40. U.K. C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 41. Italy C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 42. Russia C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 44. China C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 45. China C-X-C Chemokine Receptor Type 2 Market Share by Type (2021-2032) Figure 46. China C-X-C Chemokine Receptor Type 2 Market Share by Application (2021-2032) Figure 47. Asia C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 48. Asia C-X-C Chemokine Receptor Type 2 Market Share by Type (2021-2032) Figure 49. Asia C-X-C Chemokine Receptor Type 2 Market Share by Application (2021-2032) Figure 50. Asia C-X-C Chemokine Receptor Type 2 Market Share by Country (2021-2032) Figure 51. Japan C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 52. South Korea C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 55. India C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 56. Australia C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Share by Country (2021-2032) Figure 61. Brazil C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 62. South Africa C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 64. Turkey C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 65. Argentina C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 66. UAE C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 67. Egypt C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 68. Chile C-X-C Chemokine Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • SX-517
  • PAC-G31P
  • DF-2755A
  • AZD-5069
  • Others
Applications
  • Prostate Cancer
  • Cornary Artery Disease
  • Liver Transplant Rejection
  • Pulmonary Inflammation
  • Others
Companies covered
  • ChemoCentryx Inc
  • Dompe Farmaceutici SpA
  • Syntrix Biosystems Inc
  • AstraZeneca Plc
  • GlaxoSmithKline Plc
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global C-X-C Chemokine Receptor Type 2 Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 SX-517
  5. 1.2.3 PAC-G31P
  6. 1.2.4 DF-2755A
  7. 1.2.5 AZD-5069
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global C-X-C Chemokine Receptor Type 2 Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Prostate Cancer
  12. 1.3.3 Cornary Artery Disease
  13. 1.3.4 Liver Transplant Rejection
  14. 1.3.5 Pulmonary Inflammation
  15. 1.3.6 Others
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global C-X-C Chemokine Receptor Type 2 Growth Trends by Region
  18. 1.5.1 Global C-X-C Chemokine Receptor Type 2 Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 C-X-C Chemokine Receptor Type 2 Market Size by Region (2021-2026)
  20. 1.5.3 C-X-C Chemokine Receptor Type 2 Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global C-X-C Chemokine Receptor Type 2 Market Dynamics
  1. 2.1 C-X-C Chemokine Receptor Type 2 Industry Trends
  2. 2.2 C-X-C Chemokine Receptor Type 2 Industry Drivers
  3. 2.3 C-X-C Chemokine Receptor Type 2 Industry Opportunities and Challenges
  4. 2.4 C-X-C Chemokine Receptor Type 2 Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global C-X-C Chemokine Receptor Type 2 Revenue by Company (2021-2026)
  2. 3.2 Global C-X-C Chemokine Receptor Type 2 Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global C-X-C Chemokine Receptor Type 2 Key Company Head office and Area Served
  4. 3.4 Global C-X-C Chemokine Receptor Type 2 Company, Product Type & Application
  5. 3.5 Global C-X-C Chemokine Receptor Type 2 Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global C-X-C Chemokine Receptor Type 2 Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 C-X-C Chemokine Receptor Type 2 Players Market Share by Revenue in 2025
  9. 3.6.3 2025 C-X-C Chemokine Receptor Type 2 Tier 1, Tier 2, and Tier 3
4 C-X-C Chemokine Receptor Type 2 Market by Type
  1. 4.1 Global C-X-C Chemokine Receptor Type 2 Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global C-X-C Chemokine Receptor Type 2 Market Size by Type (2021-2032)
  3. 4.3 Global C-X-C Chemokine Receptor Type 2 Market Size Share by Type (2021-2032)
5 C-X-C Chemokine Receptor Type 2 Market by Application
  1. 5.1 Global C-X-C Chemokine Receptor Type 2 Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global C-X-C Chemokine Receptor Type 2 Market Size by Application (2021-2032)
  3. 5.3 Global C-X-C Chemokine Receptor Type 2 Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 ChemoCentryx Inc
  2. 6.1.1 ChemoCentryx Inc Company Information
  3. 6.1.2 ChemoCentryx Inc Business Overview
  4. 6.1.3 ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Product Portfolio
  6. 6.1.5 ChemoCentryx Inc Recent Developments
  7. 6.2 Dompe Farmaceutici SpA
  8. 6.2.1 Dompe Farmaceutici SpA Company Information
  9. 6.2.2 Dompe Farmaceutici SpA Business Overview
  10. 6.2.3 Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Product Portfolio
  12. 6.2.5 Dompe Farmaceutici SpA Recent Developments
  13. 6.3 Syntrix Biosystems Inc
  14. 6.3.1 Syntrix Biosystems Inc Company Information
  15. 6.3.2 Syntrix Biosystems Inc Business Overview
  16. 6.3.3 Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Product Portfolio
  18. 6.3.5 Syntrix Biosystems Inc Recent Developments
  19. 6.4 AstraZeneca Plc
  20. 6.4.1 AstraZeneca Plc Company Information
  21. 6.4.2 AstraZeneca Plc Business Overview
  22. 6.4.3 AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Product Portfolio
  24. 6.4.5 AstraZeneca Plc Recent Developments
  25. 6.5 GlaxoSmithKline Plc
  26. 6.5.1 GlaxoSmithKline Plc Company Information
  27. 6.5.2 GlaxoSmithKline Plc Business Overview
  28. 6.5.3 GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Product Portfolio
  30. 6.5.5 GlaxoSmithKline Plc Recent Developments
  31. 6.6 Novartis AG
  32. 6.6.1 Novartis AG Company Information
  33. 6.6.2 Novartis AG Business Overview
  34. 6.6.3 Novartis AG C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Novartis AG C-X-C Chemokine Receptor Type 2 Product Portfolio
  36. 6.6.5 Novartis AG Recent Developments
7 North America
  1. 7.1 North America C-X-C Chemokine Receptor Type 2 Market Size (2021-2032)
  2. 7.2 North America C-X-C Chemokine Receptor Type 2 Market Size by Type
  3. 7.2.1 North America C-X-C Chemokine Receptor Type 2 Market Size by Type (2021-2026)
  4. 7.2.2 North America C-X-C Chemokine Receptor Type 2 Market Size by Type (2027-2032)
  5. 7.2.3 North America C-X-C Chemokine Receptor Type 2 Market Share by Type (2021-2032)
  6. 7.3 North America C-X-C Chemokine Receptor Type 2 Market Size by Application
  7. 7.3.1 North America C-X-C Chemokine Receptor Type 2 Market Size by Application (2021-2026)
  8. 7.3.2 North America C-X-C Chemokine Receptor Type 2 Market Size by Application (2027-2032)
  9. 7.3.3 North America C-X-C Chemokine Receptor Type 2 Market Share by Application (2021-2032)
  10. 7.4 North America C-X-C Chemokine Receptor Type 2 Market Size by Country
  11. 7.4.1 North America C-X-C Chemokine Receptor Type 2 Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America C-X-C Chemokine Receptor Type 2 Market Size by Country (2021-2026)
  13. 7.4.3 North America C-X-C Chemokine Receptor Type 2 Market Size by Country (2027-2032)
  14. 7.4.4 North America C-X-C Chemokine Receptor Type 2 Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe C-X-C Chemokine Receptor Type 2 Market Size (2021-2032)
  2. 8.2 Europe C-X-C Chemokine Receptor Type 2 Market Size by Type
  3. 8.2.1 Europe C-X-C Chemokine Receptor Type 2 Market Size by Type (2021-2026)
  4. 8.2.2 Europe C-X-C Chemokine Receptor Type 2 Market Size by Type (2027-2032)
  5. 8.2.3 Europe C-X-C Chemokine Receptor Type 2 Market Share by Type (2021-2032)
  6. 8.3 Europe C-X-C Chemokine Receptor Type 2 Market Size by Application
  7. 8.3.1 Europe C-X-C Chemokine Receptor Type 2 Market Size by Application (2021-2026)
  8. 8.3.2 Europe C-X-C Chemokine Receptor Type 2 Market Size by Application (2027-2032)
  9. 8.3.3 Europe C-X-C Chemokine Receptor Type 2 Market Share by Application (2021-2032)
  10. 8.4 Europe C-X-C Chemokine Receptor Type 2 Market Size by Country
  11. 8.4.1 Europe C-X-C Chemokine Receptor Type 2 Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe C-X-C Chemokine Receptor Type 2 Market Size by Country (2021-2026)
  13. 8.4.3 Europe C-X-C Chemokine Receptor Type 2 Market Size by Country (2027-2032)
  14. 8.4.4 Europe C-X-C Chemokine Receptor Type 2 Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China C-X-C Chemokine Receptor Type 2 Market Size (2021-2032)
  2. 9.2 China C-X-C Chemokine Receptor Type 2 Market Size by Type
  3. 9.2.1 China C-X-C Chemokine Receptor Type 2 Market Size by Type (2021-2026)
  4. 9.2.2 China C-X-C Chemokine Receptor Type 2 Market Size by Type (2027-2032)
  5. 9.2.3 China C-X-C Chemokine Receptor Type 2 Market Share by Type (2021-2032)
  6. 9.3 China C-X-C Chemokine Receptor Type 2 Market Size by Application
  7. 9.3.1 China C-X-C Chemokine Receptor Type 2 Market Size by Application (2021-2026)
  8. 9.3.2 China C-X-C Chemokine Receptor Type 2 Market Size by Application (2027-2032)
  9. 9.3.3 China C-X-C Chemokine Receptor Type 2 Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia C-X-C Chemokine Receptor Type 2 Market Size (2021-2032)
  2. 10.2 Asia C-X-C Chemokine Receptor Type 2 Market Size by Type
  3. 10.2.1 Asia C-X-C Chemokine Receptor Type 2 Market Size by Type (2021-2026)
  4. 10.2.2 Asia C-X-C Chemokine Receptor Type 2 Market Size by Type (2027-2032)
  5. 10.2.3 Asia C-X-C Chemokine Receptor Type 2 Market Share by Type (2021-2032)
  6. 10.3 Asia C-X-C Chemokine Receptor Type 2 Market Size by Application
  7. 10.3.1 Asia C-X-C Chemokine Receptor Type 2 Market Size by Application (2021-2026)
  8. 10.3.2 Asia C-X-C Chemokine Receptor Type 2 Market Size by Application (2027-2032)
  9. 10.3.3 Asia C-X-C Chemokine Receptor Type 2 Market Share by Application (2021-2032)
  10. 10.4 Asia C-X-C Chemokine Receptor Type 2 Market Size by Country
  11. 10.4.1 Asia C-X-C Chemokine Receptor Type 2 Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia C-X-C Chemokine Receptor Type 2 Market Size by Country (2021-2026)
  13. 10.4.3 Asia C-X-C Chemokine Receptor Type 2 Market Size by Country (2027-2032)
  14. 10.4.4 Asia C-X-C Chemokine Receptor Type 2 Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Type
  3. 11.2.1 South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Application
  7. 11.3.1 South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Country
  11. 11.4.1 South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst